Efficacy and safety of trastuzumab combined with chemotherapy for first-line treatment and beyond progression of HER2-overexpressing advanced breast cancer

OBJECTIVE: To observe the efficacy and safety of trastuzumab combined with chemotherapy in patients with human epidermal growth factor receptor 2 (HER2)-overexpressing advanced breast cancer. METHODS: A total of 90 patients with HER2-overexpressing advanced breast cancer were enrolled in this study....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huiping, Shao, Bin, Yan,, Yin, Song, Guohong, Liu, Xiaoran, Wang, Jing, Liang, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949278/
https://www.ncbi.nlm.nih.gov/pubmed/27478318
http://dx.doi.org/10.21147/j.issn.1000-9604.2016.03.07

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949278/
https://www.ncbi.nlm.nih.gov/pubmed/27478318
http://dx.doi.org/10.21147/j.issn.1000-9604.2016.03.07

Ejemplares similares